ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991

Healy Saw Scripps Issue as Way To Revisit Conflict Of Interest

March 19, 1993

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009